Articles from BIOTECH Patent News (August 1, 2009)

1-23 out of 23 article(s)

Title	Type	Words
Appeals Court affirms patent infringement rulings against Roche's peg-EPO product.		344
Brinks Hofer Gilson & Lione wins patent appeal for Cook Incorporated Federal Circuit holds that Cook's Endovascular graft devices do not infringe.		616
Caraco Pharmaceutical Laboratories announces settlement of Ethyol ANDA patent litigation.		118
Cepheid receives FDA clearance for Xpert HemosIL FII & FV test 30-minute test for genetic risk of thrombosis improves time-to-result over previous molecular tests.		758
China-Biotics applies for four patents on probiotic formulations.		212
Commonwealth Scientific and Industrial Research Organization obtains United States patent.		82
Encouraging HIV/AIDS vaccine trial results support GeoVax strategy.	Clinical report	914
Evonik Degussa obtains United States patent.		101
FDA approves pralatrexate for treatment of peripheral T-cell lymphoma.		956
Gen-Probe broadens intellectual property portfolio surrounding automated nucleic acid testing.		229
GENova Biotherapeutics signs collaboration agreement with Bridge Bioresearch.		347
GENova files patent for new breast cancer treatment.		359
Isis receives notice of allowance that expands the scope of key RNA therapeutic patents for single-stranded RNAi technology.		1092
Lotus Pharmaceuticals announces patent pending Gliclazide-Controlled Release Tablets.		299
Martek announces settlement of French patent dispute with Capsugel.	Brief article	184
Merck Patent obtains United States patent.		130
NeuroTherm is awarded United States Patent for multi-lesion radiofrequency generator.		272
Oxygen Biotherapeutics, Inc. files patent application for emergency heart attack treatment device.		459
Palatin Technologies receives United States Patent allowance for heart failure drug candidate.		405
Penn State Research Foundation obtains United States patent.		250
RZN Nutraceuticals receives United States Patent and Trademark Office notice of allowance for proprietary HerbaZorb absorption and delivery.		434
United States District Court upholds validity of Lilly's Evista patents through 2014.		268
Universita Degli Studi Di Milano obtains United States patent.		140